It should also be noted that their vaccine candidate was ready in May, which only adds to the achievement. They also developed an Ebola vaccine in 2017. Clearly one of the very best teams in the world.
I don't think that they acted recklessly. In a critical emergency situation you need to be willing to take a level of risk and to balance that risk against the cost of not doing anything or of delaying doing something. From what they knew a priori about the type of vaccine (coronavirii are known and that's also what made development of vaccines quick) and the positive first trial phases they made a decision. I don't think it was a particularly risky decision but still they made it.
In fact, adverse reactions have already been tested for in previous phases. Phase III is all about effectiveness. In a pandemic it seems rational to do this testing quickly. Its defensible to do it in public trials.